Haemonetics Stock Guidance | NYSE:HAE | Benzinga

Haemonetics issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.

Get Alert
02/06/2025HAE
Haemonetics
FY2025$4.50$4.70$4.59$1.35B$1.37B$1.39BGet Alert
11/07/2024HAE
Haemonetics
FY2025$4.45$4.75$4.59$1.38B$1.41B$1.40BGet Alert
08/08/2024HAE
Haemonetics
FY2025$4.45$4.75$4.60$1.38B$1.41B$1.40BGet Alert
05/09/2024HAE
Haemonetics
FY2025$4.45$4.75$4.40$1.38B$1.41B$1.37BGet Alert
02/08/2024HAE
Haemonetics
FY2024$3.90$4.00$3.89$1.29B$1.31B$1.27BGet Alert
12/12/2023HAE
Haemonetics
FY2024$3.75$3.95$3.89$1.26B$1.29B$1.27BGet Alert
11/02/2023HAE
Haemonetics
FY2024$3.75$3.95$3.81$1.25B$1.27B$1.26BGet Alert
08/08/2023HAE
Haemonetics
FY2024$3.60$3.90$3.59$1.24B$1.27B$1.24BGet Alert
05/11/2023HAE
Haemonetics
FY2024$3.45$3.75$3.40$1.22B$1.25B$1.22BGet Alert
02/07/2023HAE
Haemonetics
FY2023$2.90$3.00$2.92$1.14B$1.16B$1.14BGet Alert
11/07/2022HAE
Haemonetics
FY2023$2.70$3.00$2.79$1.11B$1.14B$1.09BGet Alert
08/10/2022HAE
Haemonetics
FY2023$2.60$2.90$2.73$1.07B$1.10B$1.06BGet Alert
05/10/2022HAE
Haemonetics
FY2023$2.50$2.90$2.75$1.04B$1.08B$1.03BGet Alert
02/08/2022HAE
Haemonetics
FY2022$2.45$2.55$2.53$974.92M$992.33M$996.92MGet Alert
11/09/2021HAE
Haemonetics
FY2022$2.40$2.65$2.76$983.62M$1.02B$1.01BGet Alert
08/11/2021HAE
Haemonetics
FY2022$2.60$3.00$2.78$983.62M$1.03B$1.00BGet Alert
05/13/2021HAE
Haemonetics
FY2022$2.60$3.00$3.48$983.62M$1.03B$1.02BGet Alert

FAQ

Q

What is the most recent guidance for Haemonetics (HAE)?

A

The most recent guidance for Haemonetics (HAE) was reported on February 6, 2025 for the full year 2025. The company provided earnings per share guidance in the range of $4.50 to $4.70, compared to the estimated EPS of $4.59. Additionally, Haemonetics forecasted revenue between $1.35B and $1.37B for the quarter.

Browse guidance and forecast on all stocks.

People Also Watch